Owens & Minor (OMI) Competitors

$25.09
+0.97 (+4.02%)
(As of 04/26/2024 ET)

OMI vs. PDCO, PTCT, MRVI, GLPG, KROS, AMPH, BEAM, NAMS, GERN, and RNA

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Patterson Companies (PDCO), PTC Therapeutics (PTCT), Maravai LifeSciences (MRVI), Galapagos (GLPG), Keros Therapeutics (KROS), Amphastar Pharmaceuticals (AMPH), Beam Therapeutics (BEAM), NewAmsterdam Pharma (NAMS), Geron (GERN), and Avidity Biosciences (RNA). These companies are all part of the "medical" sector.

Owens & Minor vs.

Owens & Minor (NYSE:OMI) and Patterson Companies (NASDAQ:PDCO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Owens & Minor presently has a consensus target price of $23.29, indicating a potential downside of 7.19%. Patterson Companies has a consensus target price of $32.56, indicating a potential upside of 26.33%. Given Patterson Companies' stronger consensus rating and higher possible upside, analysts clearly believe Patterson Companies is more favorable than Owens & Minor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.41% of users gave Patterson Companies an outperform vote while only 48.82% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
249
48.82%
Underperform Votes
261
51.18%
Patterson CompaniesOutperform Votes
359
52.41%
Underperform Votes
326
47.59%

In the previous week, Patterson Companies had 13 more articles in the media than Owens & Minor. MarketBeat recorded 19 mentions for Patterson Companies and 6 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 0.07 beat Patterson Companies' score of -0.12 indicating that Owens & Minor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Patterson Companies
2 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
5 Very Negative mention(s)
Neutral

Owens & Minor has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

Patterson Companies has a net margin of 2.95% compared to Owens & Minor's net margin of -0.40%. Patterson Companies' return on equity of 20.98% beat Owens & Minor's return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.40% 11.62% 2.03%
Patterson Companies 2.95%20.98%7.70%

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.4% of Patterson Companies shares are owned by institutional investors. 3.6% of Owens & Minor shares are owned by company insiders. Comparatively, 1.5% of Patterson Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Patterson Companies has lower revenue, but higher earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.33B0.19-$41.30M-$0.54-46.46
Patterson Companies$6.47B0.36$207.56M$2.0312.69

Summary

Patterson Companies beats Owens & Minor on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$1.92B$7.68B$4.87B$17.47B
Dividend YieldN/A2.34%2.91%3.55%
P/E Ratio-46.4618.21188.0122.77
Price / Sales0.191.152,335.9410.49
Price / Cash4.7011.1346.7217.65
Price / Book2.082.394.754.87
Net Income-$41.30M$249.27M$103.38M$964.96M
7 Day Performance1.21%1.12%0.74%1.90%
1 Month Performance-10.23%-7.83%-7.57%-3.08%
1 Year Performance71.15%17.08%9.19%96.69%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
4.8281 of 5 stars
$25.97
+0.2%
$33.11
+27.5%
-2.3%$2.33B$6.47B12.797,600Analyst Report
PTCT
PTC Therapeutics
2.496 of 5 stars
$25.41
-2.2%
$33.53
+32.0%
-45.3%$1.95B$937.82M-3.04988Earnings Report
News Coverage
Positive News
Gap Up
MRVI
Maravai LifeSciences
3.434 of 5 stars
$7.72
+4.7%
$11.56
+49.7%
-41.8%$1.94B$288.95M-8.58650Short Interest ↑
GLPG
Galapagos
0.3672 of 5 stars
$29.45
+1.3%
$34.50
+17.1%
-26.5%$1.94B$259.40M-12.861,123Upcoming Earnings
Short Interest ↑
KROS
Keros Therapeutics
2.0601 of 5 stars
$55.19
-1.1%
$86.00
+55.8%
+33.0%$1.99B$150,000.00-10.61136Upcoming Earnings
AMPH
Amphastar Pharmaceuticals
4.7759 of 5 stars
$40.91
+1.8%
$66.00
+61.3%
+7.7%$2.00B$644.40M15.861,761Short Interest ↑
Positive News
BEAM
Beam Therapeutics
2.7992 of 5 stars
$23.47
-2.6%
$41.00
+74.7%
-30.0%$1.92B$377.71M-12.35436Analyst Report
NAMS
NewAmsterdam Pharma
3.1033 of 5 stars
$21.45
+6.0%
$33.25
+55.0%
+57.1%$1.91B$14.09M0.0029Positive News
GERN
Geron
2.9062 of 5 stars
$3.50
-6.2%
$5.33
+52.4%
+56.0%$1.91B$240,000.00-10.61141Upcoming Earnings
Short Interest ↑
News Coverage
RNA
Avidity Biosciences
1.1314 of 5 stars
$25.14
+4.1%
$36.33
+44.5%
+40.5%$2.00B$9.56M-8.67253

Related Companies and Tools

This page (NYSE:OMI) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners